Evidence map›Paper›PMID 32369578›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA's Diagnostics Committee.

Kimberly E Hanson, Marwan M Azar, Ritu Banerjee, Andrew Chou, Robert C Colgrove, Christine C Ginocchio, Mary K Hayden, Mark Holodiny, Seema Jain, Sophia Koo and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 2 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 2 syntheses or guidelines pooled it, 169 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Streptavidin-DisplayingSensors (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Current practice and timing of rapid point-of-care testing for acute respiratory tract infections in outpatient care: a retrospective cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Challenges and opportunities in the management of severe pneumonia. Key concepts from the Seventh Annual Meeting of Spanish Experts 2025.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Review
  12. Impact of Methicillin-ResistantOpen forum infectious diseases · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 12 institutions in 1 country.

Kimberly E HansonDivision of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Marwan M AzarDepartment of Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, USA.
Ritu BanerjeeDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Andrew ChouMichael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, Texas, USA.
Robert C ColgroveDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Christine C GinocchioGlobal Medical Affairs, bioMérieux/BioFire Diagnostics, Salt Lake City, Utah, USA.
Mary K HaydenDivision of Infectious Diseases, Department of Medicine, Rush University Medical Center, Chicago, Illinois, USA.
Mark HolodinyVA Palo Alto Health Care System, Palo Alto, California, USA.
Seema JainDisease Investigations Section, Infectious Diseases Branch, California Department of Public Health, Richmond, California, USA.
Sophia KooDivision of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Jaclyn LevyInfectious Diseases Society of America, Arlington, Virginia, USA.
Tristan T TimbrookDivision of Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah USA.
Angela M CaliendoDivision of Infectious Diseases, Department of Medicine, Brown University Warren Alpert School of Medicine, Providence, Rhode Island, USA.
University of Utah · USbioMérieux (United States) · USBrigham and Women's Hospital · USBrown University · USCalifornia Department of Public Health · USHarvard University · USInfectious Diseases Society of America · USMichael E. DeBakey VA Medical Center · USRush University Medical Center · USVanderbilt University Medical Center · USVA Palo Alto Health Care System · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
CSRD VA IK2 CX001981NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

The clinical signs and symptoms of acute respiratory tract infections (RTIs) are not pathogen specific. Highly sensitive and specific nucleic acid amplification tests have become the diagnostic reference standard for viruses, and translation of bacterial assays from basic research to routine clinical practice represents an exciting advance in respiratory medicine. Most recently, molecular diagnostics have played an essential role in the global health response to the novel coronavirus pandemic. How best to use newer molecular tests for RTI in combination with clinical judgment and traditional methods can be bewildering given the plethora of available assays and rapidly evolving technologies. Here, we summarize the current state of the art with respect to the diagnosis of viral and bacterial RTIs, provide a practical framework for diagnostic decision making using selected patient-centered vignettes, and make recommendations for future studies to advance the field.

Indexed as

COVID-19Respiratory Tract InfectionsVirusesHumansMolecular Diagnostic TechniquesSARS-CoV-2molecular diagnosticsrespiratory virusesutilization

Identifiers

PMID32369578
PMCPMC7454374
OpenAlexW3021346431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.